Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

TGRX-814

Aliases
TGRX-814 monotherapy

1 clinical trial

6 indications

Indication
hematologic malignancies
Indication
Non-Hodgkin Lymphoma
Indication
Acute Myeloid Leukemia
Indication
Acute Lymphoblastic Leukemia
Indication
Adult
Indication
Myelodysplastic Syndromes
Clinical trial
A Single-arm, Open-label, Dose Escalation and Expansion Phase I/II Study Evaluating Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TGRX-814 Monotherapy and Combination Therapy in Patients With Hematological Malignancies
Status: Recruiting, Estimated PCD: 2025-02-28